Form 4 holding
EVP & Chief Financial Officer
Jazz Pharmaceuticals plc
- Security class
- Ordinary Shares
- Shares / value
- 56,431
- Estimated value
- $10,668,280
- Report date
- 30 Jun 2026
- Price
- $189.05
- Ownership
- Direct
Philip L. Johnson - EVP & Chief Financial Officer at Jazz Pharmaceuticals plc
Issuer-level insider activity
- Role
- EVP & Chief Financial Officer
- Issuer ticker
- JAZZ on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Philip L. Johnson since 20 Sep 2025
Reported holdings for Philip L. Johnson in Jazz Pharmaceuticals plc
Transaction history for Philip L. Johnson in Jazz Pharmaceuticals plc
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.